• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    FDA Clears NovelMed`s SC Ruxoprubart for PNH on Phase II Data

    GLOBENEWSWIRE

    US FDA approves NM8074 (Ruxoprubart) IND for treating Dermatomyos

    GLOBENEWSWIRE

    FDA Approves Phase II Clinical Trial For Ruxoprubart In ANCA Vasculitis

    GLOBENEWSWIRE

    NovelMed Commences Phase II Trial for Anti-Bb Antibody (NM8074)

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.